You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that Prof. Dr. Enzo Tramontano has been appointed as the Associate Editor of the Section “Viral Immunology, Vaccines, and Antivirals” in Viruses (ISSN: 1999-4915).
Name: Prof. Dr. Enzo Tramontano
Affiliation: Chair, Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato SS554, Monserrato, 09042 Cagliari, Italy
Interests: virology; antiviral drugs; drug development; endogenous retroviruses; viral escape of innate immunity
Prof. Dr. Enzo Tramontano is a Professor of microbiology and Chair of the Department of Life and Environmental Sciences at the University of Cagliari (Italy), and is currently the Vice-President of the Italian Society for Virology (SIV-ISV). His research activities focus on the i) discovery and development of antiviral agents; ii) understanding the molecular mechanism of innate immunity viral evasion; iii) study of the expression of retroviral sequences stably integrated into human genomes to explore their physiological and pathological role.
The following is a short Q&A with Prof. Dr. Enzo Tramontano, who shared his vision for the journal with us, as well as his views of the research area and Open Access publishing:
1. What appealed to you about the journal that made you want to take the role as its Associate Editor?
It is a relatively new, well-respected international scientific journal with a dynamic Editor-in-Chief and a strong and diversified Editorial Board. I believe it will be an exciting task.
2. What is your vision for the journal?
The journal should be a platform of excellence for virology research, providing cutting-edge high-quality research papers and accurate review articles focused on prominent topics. In addition, I believe it must also contribute to inspiring a new generation of virologists with a passion for questions and discoveries, as well as the scientific rigor for investigating them.
3. What does the future of this field of research look like?
Viruses are an essential component of our planet. The COVID-19 pandemic has reminded us how they may impact our daily life, but their role far exceeds their pathological effects. Virology is a rising field in which new basic knowledge may lead to many novel technological advances, as it has already been proven historically.
4. What do you think of the development of Open Access in the publishing field?
The Open Access policy addresses the need of improving the diffusion of scientific information, speeding up technological innovation and boosting the benefits of public investment in research. Open Access may also improve the impact of science outside the scientific community, reaching a wider audience on relevant topics.
We wish Prof. Dr. Enzo Tramontano every success in his new position, and we look forward to his contributions to the journal.